Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01256125|
Recruitment Status : Unknown
Verified October 2010 by Sun Yat-sen University.
Recruitment status was: Recruiting
First Posted : December 8, 2010
Last Update Posted : December 8, 2010
|Condition or disease|
|Allogene MSCs Transplantation Chronic Liver Diseases Patients Peripheral Vein|
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Observational Model:||Case Control|
|Official Title:||Therapeutic Effects of Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.|
|Study Start Date :||October 2010|
Allogene MSCs transplantation
Allogene MSCs transplantation were performed in patients with chronic liver diseases through peripheral vein plus the same medical treatments.
only medical treatments were performed in patients with chronic liver diseases.
- Short-term therapeutic effects at 1-8 weeks after Allogene MSCs transplantation through peripheral vein. [ Time Frame: 1-8 weeks after transplantation ]
- Long-term follow-up of Allogene MSCs transplantation through peripheral vein. [ Time Frame: 3-60 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01256125
|Department of Infectious Diseases, 3rd Affiliated Hospital of Sun Yat-sen University||Recruiting|
|GuangZhou, Guangdong, China, 510630|
|Contact: Liang Peng, Dr. +86-013533978874 email@example.com|
|Contact: Jing Liu, Master +86-013556051920 firstname.lastname@example.org|